Why the study?
Does intrapericardial instillation of tetracycline hydrochloride control signs and symptoms of tamponade in patients with malignant pericardial effusion?
Does intrapericardial instillation of tetracycline hydrochloride control signs and symptoms of tamponade in patients with malignant pericardial effusion?
Intrapericardial tetracycline sclerosis is a safe, simple, and efficacious palliative treatment for cardiac tamponade secondary to malignant pericardial effusion.
Answers are grounded in this paper and cite their sources.
May support tetracycline sclerosis for malignant tamponade palliation; leaves open confirmation in prospective trials.
Thirty-three unselected patients with cardiac tamponade secondary to malignant pericardial effusion were treated by intrapericardial instillation of tetracycline hydrochloride. Complete control of the initial signs and symptoms of tamponade was obtained in 30 patients without concomitant chemotherapy or radiotherapy. The procedure did not result in clinically significant complications. Failure of the technique was related to premature removal of the catheter by the patient (one patient) or the inability to totally remove hemorrhagic, clot-filled pericardial fluid (two patients). Survival ranged between 28-704 days and extended survival was related to the performance status and/or chemoradiosensitivity of the primary cancer. No patient successfully treated subsequently developed recurrent cardiac tamponade or alternatively, constrictive pericarditis. Tetracycline pericardial instillation remains a safe, simple, and efficacious treatment of tamponade secondary to malignant disease.
No takes yet. Share an insight, caveat, or question.
Davis et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: